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IgM reactive with the Fc portion of self IgG can be elicited in the mouse by
bacterial LPS (1-3), secondary protein immunization (4-6), or injection of
immune complexes (7, 8). Secondary immunization also induces IgM anti-IgG in
humans and rabbits (9, 10), and similar antibody has been found in rats (11).
This autoantibody has been termed rheumatoid factor (RF)' because of its
resemblance to IgM and IgG anti-IgG present in the serum of patients with
rheumatoid arthritis (12). As an autoantibody response, the production of IgM
anti-IgG is unusual in a number of respects: (a) it is not usually pathogenic or
associated with a pathologic state; (b) it is a normal component ofthe secondary
immune response, its production being stimulated by immune complexes formed
during the response; (c) its production is regulated, peaking sharply at day 3 and
falling to background in 1-2 wk; and (d) the percentage of B cells that can
produce the antibody is strikingly high (1-8).
We have been intrigued by the high frequency of B cells that can make IgM
anti-IgG. As many as 3-15% ofhybridomas induced by the polyclonal activator
LPS producethis type ofantibody, most ofwhich are specific for IgG1 (reference
3; D. Carson, unpublished results;J. Van Snick, unpublished results) . The same
frequency has been observed among hybrids elicited specifically via secondary
immunization with protein antigens (5). The fraction of anti-IgG clones among
LPS hybridomas is much higher than the fraction that binds toa variety ofother
antigens (13-18).
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There are three plausible models to explain the high frequency of anti-IgG B
cells. The "multiple epitope" model posits that there is an unusually large number
of antigenic epitopes on IgG Fc, each with an ordinary frequency of B cells that
can recognize it. A prediction is that sequences ofanti-IgG antibodies will appear
random since these antibodies are directed against a mixture of a large number
of different epitopes. The "constant stimulation" model hypothesizes that con-
stant exposure to autoantigen leads to vast clonal expansion of an ordinary
number of precursors. The sequences of B cells that are derived from greatly
expanded clones are expected to harbor large numbers of somatic mutations,
since this process accompanies clonal expansion. The premise of the "combina-
torial" model is that the presence on an antibody of a single V region structure
(e .g., a particular V, VK, J., etc.) is sufficient to confer the ability to bind IgG
Fc. Since such single structures would be expressed in a high percentage of B
cells, this model suggests a possible structural explanation for a high precursor
frequency of anti-IgG B cells.
Since these models make different predictions about the nature of V regions
of IgM anti-IgG 1 antibodies, we sought to distinguish between them by deter-
mining the sequences of such V regions expressed in monoclonal IgM anti-IgG1
antibodies . The data obtained support the combinatorial model and contradict
the constant stimulation and multiple epitope models . In addition, the sequences
suggest that the IgM anti-IgG1 autoantibodies may be binding IgGI through an
unusual combining site.
Materials and Methods
Hybridomas. Each hybridoma is derived from a separate fusion, except RF49 and
RF51 . The "JV" hybridomas were produced by fusion with SP2/0 and tested essentially
as described (3, 5). JV6 is derived from a secondary immunization with DNP-human
apolactoferrin . The "RF" hybridomas were produced from mice given 50,ug of LPS 3 d
before fusion. Splenocytes from these mice were hybridized either with Ag8 (RF34) or
SP2/0 (RF49 and RF51). Hybridomas were screened for binding of IgG of all mouse
isotypes in an ELISA which detected bound IgM. Hybrids were subcloned and retested
before use. VS 1 and VS2 were produced from mice immunized with KLH . VS3 and VS4
were made from splenocytes of LPS-immunized mice. SP2/0 is the fusion partner in "VS"
hybridomas.
RNA Preparation.
￿
Total cellular RNA was prepared by the guanidinium isothiocyanate
method, essentially as described by Chirgwin et al. (21). Poly(A)+-RNA was isolated on
oligo(dT)-cellulose columns by standard methods (22).
Oligonucleotide Primers.
￿
K and 1 oligonucleotide primers were synthesized using phos-
photriester chemistry either manually or by an oligonucleotide synthesizer (Applied
Biosystems, Inc., Foster City, CA). Oligonucleotides were purified by electrophoresis
through 40-cm 20% polyacrylamide/7 M urea preparative gels, followed by passive
elution and Sephadex-DEAE chromatography. The sequences are (K) 5'-TGGATGGTG-
GGAAGATG-3', and (,u) 5'-GCAGGAGACGAGGGGGA-3' .
cDNA Synthesis andPurification.
￿
50 ng of oligonucleotide primer was labeled with
32P
at the 5' end with 10 U T4 polynucleotide kinase (Pharmacia Fine Chemicals, Piscataway,
NJ) for 1 h at 37°C in the following reaction mix: 50 mM Tris-Cl (pH 7.6), 5 mM DTT,
0.1 mM spermidine, 0.1 mM EDTA, and 10 MM MgC12. The reactions were boiled for 2
min to inactivate the kinations enzyme. Kinations were then added to 30-60 Ag of
poly(A)+-RNA and the mixture was heated to 90'C for 2 min. The mixtures were allowed
to slow-cool for 20 min. The RNA-kination mixture was then adjusted to 100 mM Tris-
CI (pH 8.3), 140 mM KCI, 10 MM MgCl2, 0 .5 mM deoxyribonucleic triphosphates (dNTPs)
(PL Biochemicals, Milwaukee, WI), 10 mM DTT, 120 U RNasin (Promega Biotec,SHLOMCHIK ET AL.
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Madison, WI), 40 U reverse transcriptase (Life Sciences, St. Petersburg, FL), and cDNA
synthesis was allowed to take place for 2 h at 42'C. The reaction was stopped by
adjustment to 150 ug/ml boiled RNAase (Sigma Chemical Co., St. Louis, MO), 15 mm
EDTA, and further incubation at 42°C for 30 min . The reaction was then extracted once
with an equal volume of 25:24:1 phenol/chloroform/isoamyl alcohol and then back-
extracted with an equal volume of Tris/EDTA (10:1, pH 8.0). Aqueous phases were
pooled and brought to 0.3 M sodium acetate with 4 M sodium acetate (pH 6.0) and
precipitated with ethanol. Dried pellets were resuspended in dH20 and formamide dyes
and run on a 5% polyacrylamide 7 M urea gel for 2-3 h at 30 vol/cm. The gel was
exposed to film for 5-10 min and the exposure was used to locate and excise relevant
full-length cDNA transcripts, which usually contained the vast majority of incorporated
radioactivity. Gel slices were chopped and incubated, shaking at 37 °C overnight in a
solution of 0.5 M ammonium acetate with I mM EDTA. The aqueous phases were drawn
off and passed over a column of siliconized glass wool. 6.4 ug of sonicated salmon sperm
DNA (sssDNA) was added and the solutions were precipitated with 2.5 vol ethanol. Pellets
were redissolved in 0.3 M sodium acetate (pH 7.0) and reprecipitated with 2.5 vol ethanol.
Pellets were then washed twice with 70% ethanol, once with 100% ethanol, and then
dried. Finally, the pellets were redissolved in an appropriate volume of dH20 before
aliquotting for sequencing.
Modified Chemical Degradative Sequencing.
￿
Reactions were modified from Rubin and
Schmid (23) and Bencini et al . (24) as follows: 10 Al of labeled cDNA solution was
aliquotted to each of four microfuge tubes, labeled A > C, G + A, C, T > G. 1 Al of
sssDNA was added to the C and T > C tubes and the following reactions were carried
out: A > C, add 2 Al of 3 .75 M NaOH, incubate at 90° C for 9 min, cool on ice 3 min,
add 150 Al 1 M piperidine; G + A, add 2 ul 0.5 M sodium formate (pH 2.0), incubate at
37 ° C for 15 min, add 150 Al 1 M piperidine, and keep on ice; C, heat 2 min at 90 °C,
cool 2 min on ice, add 20 Al of 4 M NH20H (pH 6.0 with diethylamine), incubate 23°C
for 8 min, stop by adding 400 Al of cold 0.3 M sodium acetate, pH 7.0, and 20 ug/ml
tRNA and 1 ml ethanol, freeze on dry ice for 5 min, and spin in a high speed microcen-
trifuge for 10 min. Resuspend in 300 Al 0.3 M sodium acetate, pH 7 .0, and add 900 Al
ethanol, freeze, and spin again. Wash once with 70% ethanol, once with 100% ethanol,
and dry. Resuspend in 150 AI 1 M piperidine; T > G, heat 2 min at 90° C, cool 2 min on
ice, add 20 Al of 0.04 mg/ml KMn04 and incubate at 23°C for 8 min, stop by adding 10
Al allyl alcohol, dehydrate by adding 1 ml 1-butanol, vortexing, and spinning for 2 min,
resuspend pellet in 150 Al dH20 and add 1 ml butanol, vortex, and spin, dry, and
resuspend in 150 Al 1 M piperidine. Incubate all reactions at 90°C for 30 min, cool on
ice for 3-4 min, add 150 Al 70% ethanol to the A tube, and fill microfuge tubes almost
to volume with 1-butanol, vortex, and spin for 2 min. Remove supernatants and add 150
Al 1 % SDS to pellets, add 1 ml 1-butanol, vortex, spin 2 min, remove supernatants, add 1
ml ethanol, spin 3 min, remove supernatants, and dry. Resuspend in dH20 and formamide
dyes and run on 80-cm 5% polyacrylamide linear gels and 80-cm 6% buffer-gradient
polyacrylamide gels (25). In contrast to direct dideoxy-sequencing of mRNA (26), partial
chemical degradation of a full-length cDNA nearly always allows the unambiguous
determination of all bases up to ^-400 nucleotides from a single primer hybridization site.
IgM Anti-IgG1 Light Chain Sequences
Results
The light chain nucleotide sequences from nine IgM hybridomas that bind
IgGI have been determined; they are summarized in Table I and presented as
amino acid translations in Fig. 1 . There are 10 light chain sequences from 9
hybridomas because RF49 synthesizes two very similar light chain mRNAs,
neither of which has any defects in the sequenced region, including the leader
sequences (data not shown), that would make them untranslatable. RF49 also
produces two VK proteins, both of which associate with heavy chain in binding41 0
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TABLE I
BALB/c IgM Anti-IgG (RF) Hybridoma Characteristics Summary
V region group assignments were made on the basis of>80% nucleicacid homology to prototype sequences.
* The VS series was produced by Sato and Nemazee,the RF series by Carson, and theJV series by Van Snick.
I All germline De genes that the sequenced De could have been derived from are given.
4 RF49 makes two light chains, both ofwhich are V 19 type and both of which associate with the heavy chain to bind IgG, (see text).
The A chain is the gene used in MPCI I and is identical in sequence to RF51.
IgG. The number of restriction fragments detected with C, andJ. probes in Bam
HI- and Hind III-digested RF49 DNA indicates that RF49 is probably not the
result of two spleen cells fusing with one SP2/0 cell (data not shown).
The light chains fall into only 3 of 24 known "families," according to the
classification scheme proposed by Potter et al. (27) . This system groups closely
related sequences into families based on the relatedness of N-terminal amino acid
sequences. The families identified in the IgM anti-IgGI sequenced here are: Vxl
(two examples), Vx8 (three examples), and Vx 19 (five examples).
An apparent bias in Vx gene usage among RFs prompted us to calculate
whetherthe light chain usage in RFs deviated significantly from random selection
from the pool of expressed Vx genes. For this calculation, it is necessary to know
the fraction of expressed VK which each VX group comprises in unselected adult
BALB/c B cells. This information has not been determined directly; however, a
source of suitable data comes from two types of studies.
The analysis of Ig variable regions produced by independently induced plas-
macytomas and LPS-derived hybridomas is one approach to sampling of the
normally expressed pool of V regions. Surveys of this type have provided detailed
information on the relative expression of many Vx families (27-29, see below).
Although some biases may exist in the genesis of plasmacytomas, which could
affect the V repertoire being expressed in such tumors, the V region represen-
tation generally parallels that of serum Ig (30).
The germline gene composition of each Vx family is a second source (31, 32).
The assumption in applying this data is that, in terms of gene families, the
selection of germline genes for expression is essentially unbiased . Several exper-
imental approaches have found that, in adults, V gene usage is approximately
commensurate with representation in the germline for most V genes (18, 28,
33-37).
To provide two different estimates of whether VK genes used in RFs are a
random sampling of all VK genes, we have made calculations based on data from
both the germline pool, as measured by probing Southern blots of germline
Hybri-
doma*
Specificity Induction VK group JK Vx group Jx
CDR3
length
VSl IgGI Secondary response 1 1 J606 3 Q52 8
to protein Ag
VS2 IgGI Secondary response 19 1 7183 I FLI6.1 10
to protein Ag
VS3 IgGI LPS 8 2 J558 4 2 8
VS4 IgGI LPS 8 1 J558 3 FL16.1 or .2 7
RF49s IgG3 > IgGI LPS 19 (A chain)4 2 Not known - - -
19 (B chain) 1
RF51s IgGI LIPS 19 (MPCI I gene) 2 J558 2 SP2.3, .4, .6 8
RF34 IgGI LPS 19 (MOPC21 gene) 2 J558 4 any SP2 8
JV2 IgGI LPS+dextran 8 1 J558 2 7
JV6 IgGI Secondary response 1 1 J558 4 FL16.1 or .2 9
to protein AgFIGURE 1.
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IgM anti-IgGI (RF) VS amino acid sequences and control VK sequences. The RF
amino acid sequences are inferred from the complete mRNA nucleotide sequences. Dashes
indicate identity with the topmostsequence, which is given explicitly. Blankspaces are used to
align sequences of different lengths for maximum homology. Framework (FR) and hypervar-
iable (HV) regions, as defined by Kabat et al . (47), are indicated. The V, groupto which each
sequence belongs, as defined by Potter et al . (25), is given in parenthesis after the name. The
N-terminal 12 residues ofVS2 have notbeen determined andare indicatedby emptybrackets,
as are two missing residues from MOPC173B. RF49 makes two productive V, chains (see
text); they aregiven as "RF49 Kappa A" and "RF49 Kappa B."
DNA with VK probes, and the expressed pool, as measured by sequencing and
electrophoretic analysis of proteins made by plasmacytomas. Estimates for the
total pool size ofgermline (31) and expressed (27, 28, 31, 35) genes are similar
and are in the range of 100 to 300. It should be noted that these values are likely
to be underestimates (see discussion in references 27, 28, and 35).
Table II shows the results ofthese calculations. The different estimates ofthe
fraction of the germline and of the expressed VK genes which each group
comprises and the corresponding p values are given. The sizes ofeach ofthe VK
families are derived as follows: VK19 probes hybridize to seven bands in Southern
blots of BALB/c liver DNA (31, 38). Assuming that the average band contains
one gene (i.e., that each band represents one unique hybridizing restriction
fragment and that each restriction fragment contains one gene) (31, 39, 40),
VK19 represents at most (since some bands may represent psuedogenes [41, 42])
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FRI HV1 FR2 HV2
I 127obcdef28 I I
RF49 KAPPA A k19 DIVMTOSHKFMSTSVGDRVSITC KASQ DVSTTVA WYQOKPGQSPKLLIY SASYRYT
RF49 KAPPA B k19 ----------------------- ---- ----e-- --------------- -------
RF51 KAPPA k19 ---- ------- --------------- -------
VS2 KAPPA k19 I
I--------V-- ---- T-G-N-- -----------A--- --T---S
RF34 KAPPA k19 N------P----T---E--TL-- ---E N--Y--S ------E-------- G--N---
VS3 KAPPA k8 -------PSSL-V---EK-TMS- -S--SLLNSGNQKNYL- --------P------ G--T-ES
VS4 KAPPA k8 -------PSSLAM---OK-TMS- -S--SLLNSSNQKNYL- -------------V- F--T-ES
JV2 KAPPA
~kl
k8 -------PSSLAM---QK-TMS- -S--SLLNSSNOKNYL- -------------V- F--T-ES
VS1 KAPPA k1 -VL---TPLSLPV-L--QA--S- RS--SIVHS NGN-YLE --L------------ KV-N-FS
JV6 KAPPA -VL---TPLSLPV-L--QA--S- RS--SIVHS NGN-YLE --L------------ KV-N-FS
Length Group 35 Control Sequences
VK2 (k12-13 --Q----PASL-A---ET-T--- R--G NIHNYL- -----O-K--Q--V- N-KTLAD
MOPC149 KAPPA --Q----PDYL-A---ET-T--- R--E NIYSYL- -----O-K--Q--V- D-KTLVE
MOPC41 KAPPA
¬ k9
k9 --0----PSSL-A-L-E---L-- R--- -IGSSLN -L--E-DGTI-R--- AT-SLDS
MOPCI73B KAPPA --0----PSSL-A-L-E---L-- R--- -fHGYLN LF----- ETI-H--- ET-NLDS
VKL7 (k23 --LL---PAIL-V-P-E--- FS- R--- SIG-SIH ---- RTNG--R---K Y--ESIS
MOPC173 KAPPA (k10 --O--GTTSSL-A-L----T--- S--- SIGNY(I ------DGTV----- YT-SLHS
R16 .7CR1+ KAPPA (" --Q---TTSSL-A-L----T-S- R--- -I-NYLN ------DGTV----- YT-RLHS
W3082 KAPPA (k11 -VQ-I--PSSL-A-L--I-TM-- 0--- GTNINLN -F-----KA------ G--ILOD
1606 KAPPA (k11 -VQ-I--PSSL-A-L--I-TM-- 0--- GT-INLN -F-----KA------ G--NLGD
FR3 HV3
I
FR4
I
RF49 KAPPA A
I
GVPDRFTGSGSGTDFTFTISSVQAEDLAVYYC OOHYSTPPT FGGGTKLEI
RF49 KAPPA B -------------------------------- -------W- ---------K
PF51 KAPPA -------------------------------- --------- ---------KRLM
VS2 KAPPA ----------------L---N--S----E-F- --YN-Y-L- ---------KRL
RF34 KAPPA -----------A----L-----------D-H- G-G--Y-Y- --------
VS3 KAPPA ---------------- L---G-------F--- RNDHTY-YM ---------KR
VS4 KAPPA ------I---------L-----------D-F- -------Y- ---------KRL
JV2 KAPPA ------I---------L-----------D-F- ----T--W- ---------K
VS1 KAPPA ------S---------LK--R-E---- G---- F-GSHV-R- ---------KRL
JV6 KAPPA ------S---------LK--R-E---- G---- F-GSHV-W- ---------KR
VK2 ---S--S------QYSLK-N-L-P--FGS--- -HFW---
MOPC149 KAPPA ---S--S------Q-SLK-N-L-P--FGS--- -H--GI-FR --S------
MOPC41 KAPPA ---K--S--R--S-YSL----LES--FVD--- L-YA-S-W- ---------K
MOPCI73B KAPPA ---K--S--R--S-YSLI-G-LES--F-D--- L-YA-S--
VKL7 -1-S--S---------LS-N--ES--I-D--- --SN-W-
MOPC173 KAPPA ---S--S-------YSL---DLEP--I-T--- --YSKL-R- ---------K
R16.7CPI+ KAPPA ---S--S-------YSL---NL000-I-T-F- --GN-L-R- -------G-K
W3082 KAPPA ---S--S--RY-----L----LED--M-T-F- L--TYL-Y- ---------K
J606 KAPPA ---S--S--RY-----L----LED--M-T-F- L--SYL-Y- ---------K41 2 VARIABLE REGION SEQUENCES OF RHEUMATOID FACTORS
TABLE II
The Significance of Restricted V, Usage in the RF by V, Group Based on Different Estimates of
Group Representation in the V, Pool
Different estimates of the representation of the V, groups in the pool of available V, genes and the
respective p values based on those estimates are given. The null hypothesis under test is that, for
each individual V, family, the representation in the sample is consistent with random selection from
the general population. Therefore, p values are the binomial probabilities of selecting at random a
sample containing the observed number of hybridomas expressing the lightchain from the given V,
group from the general population. Thecomposition of the general population is notexactly known,
andso, as discussed in the text, is estimated from data derivedfrom severalexperimental approaches.
Several estimatesareused to show the effect that error in the estimate wouldhave on ourconclusions.
The estimates described in the text are referred to in the column "Basis of estimate." Briefly, the
number of germline genes in each family is based on Southern blotting data. The total number of
V, genes is conservatively assumedto be 100, based on a minimum valuefrom several estimates.The
percentage of expression in BALB/c myelomas is taken from reference 28. See text fordetails and
further references.
7 out of 100 of the germline pool. With a VK8 probe, six to eight bands were
detected by Southern blotting (reference 31 and L. D'Hoostelaere, personal
communication). For V,1, two bands are detected in a Southern blot (32 and L.
D'Hoostelaere, personal communication). BALB/c plasmacytoma libraries con-
tained 2% V,19-, 2% V,8-, and 6-12% V,1-expressing tumors (28). The V,1
gene family seems to be one ofonly 3 out of 65 groups that was overrepresented.
In the NZB tumors, the V,1 family, which is encoded in the NZB genome by a
different set of highly homologous genes (32), was not overrepresented (28).
Using the germline gene estimate for the fraction ofthe pool that each group
occupies, the p values indicating nonrandom expression of the groups are: V,1,
0.014; VK8, 0.03; and V,19, 0.002. Thus, a limited set of V, genes, roughly
representing 5-17% of germline V,s and 10-16% of expressed V,s, is found in
IgM anti-IgG hybridomas. Considering the selection ofV,s as a whole, ifeach of
the 24 V, families were equally likely to be selected in RFs, then the chance that
three or fewer different families would be seen in nine trials is 1 .4 x 10-5.
V, group
Number
of times
observed
Estimated
fraction of
V, gene pool
Basis of estimate p value
1 2 0.02 2 per 100 germline genes 0.014
0.06 Percent of BALB/c myelomas expressing 0.10
V,1C only
0.12 Percent of BALB/c myelomas expressing 0.30
V,1C and V,IA
0.04 Maximumfraction of pool forp< 0.05 with -0.05
this data
8 3 0.08 8 per 100 germline genes 0.03
0.02 Percent of BALB/c myelomas expressing 0.002
V,8
0.10 Maximumfraction ofpool forp< 0.05 with ^"0.05
this data
19 4 0.07 7 per 100 germline genes 0.002
0.02 Percent of BALB/c myelomas expressing 0.00002
V,19
0.17 Maximumfraction ofpool forp< 0.05 with -0.05
this dataVJi Gene Sequences
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FIGURE 2.
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IgM anti-IgGI (RF) 1A chain sequences. Sequences are derived and presented as
in Fig. 1. The V sequences of J558, MOPC21, and J606 (taken from reference 47) are
presented forcomparison . The variable-length CDR3 sequences have been aligned for maxi-
mum homology.
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The heavy chain sequences for eight IgM anti-IgG were determined and are
presented as amino acid translations in Fig. 2 and summarized in Table I. The
RF49 heavy chain was not sequenced because the cell line lost production of
heavy chain mRNA during propagation before preparation of RNA. The same
type of analysis applied to the light chains to test if they constitute a randomly
selected set can also be applied to the heavy chains. There are eight described
V gene families constituting 100-200 genes (39, 43). Heavy chain gene families
have been characterized in the germline as sets of nonoverlapping bands, detected
in Southern blots by a series of V,, probes under a stringency that would detect
80% homology. Interfamily homologies, as determined by sequencing repre-
sentative members, are 50-70% (39). As noted above, it has been shown that
the adult expresses particular V genes or gene families roughly in proportion
to their representation in the germline repertoire (18, 33, 34, 36).
The sample of IgM anti-IgGs described here includes six members of theJ558
family, and one each from 7183 andJ606 families (see references 39 and 43 for
a description of VH families). This would seem to show a preference for members
of theJ558 family; however, this family encompasses ^-60-70% of the germline
V genes (39, 43). Thus, finding J558 V genes in 75% of the IgM anti-IgG
hybrids does not constitute a statistically significant preference for usage of
members of this family.J606 and 7183 each constitute -10% of the germline V
genes; their presence in one of eight examples is not unexpected in a random
selection model. For heavy chains, then, the null hypothesis of random selection
cannot be rejected . It should be noted, however, that the two nonJ558 V
sequences occurred in hybridomas made from secondary protein, immunization-
stimulated cell fusions. One other hybrid made in this way does contain a J558
heavy chain. Thus it is possible (but not significant with this sample size) that
J558 VH
MOPC21 VH (7183)
-___-_----___-----_M_----__T_- D-Y-K ---------5---- D--- N--G-S----FK-
D---VE--GG--Q--G-R-L--A--- FT-5 SFG-H --R-APE-G---VA Y-SS GSSTLH-ADT-K-
J606 VH --K-EE--GG--Q--G-M-L--V---FT-S N-W-- --R--PE-G---VA E-RLKSN-YA-H-AES-K-
FR3 HV3 FR4
PF51 MU
I
KATLTVDKSSSTAHMELLSLTSEDSAAYYCGR
I I
SGYDG FDY WGQGTTLTVSSE
VS2 MU RF-ISR-NAEN-LYLQMS--K---TVL---A- RSGSSHWS--V --
PF34 MU -------------------------- V----- ---Y_ M-- _____S
VS3 MU -------------------------- V----- GALYA M-- -----SV----
VS4 MU ----------------- R__A__-__V___A- E__YV A_ -----LV___A
JV2 MU -------------------------- V----- ___y
V51 MU RF-ISR-D-K--VYLOMNN-RA--TGI---T- PELGW -A- -----LV-
JV6 MU __---_--__---Y-0_S--------V_--T- __GNYVG -- -----Sl.,___-
J558 VH ------------- Y_0_N-------- V___AT D
MOPC21 VH RF-ISR-NPKN-LFL0MT--R---T-MD--A-
J606 VH RF-ISR-D-K-SVYLOINN-RA--TGI---T-
FR1 HV1 FR2 HV2
PF51 MU J558
I I I
EVOLQOSGPELVKPGASVKISCKASGYSFT GYFMN WVKQSHGKSLEWIG RINP YNGDTFYNOKVJG
VS2 MU 7183 G
--------------------------------
LFT=S S-Y-S --R-TPE-R--LVA A--T NG-S-Y-PDT-K-
PF34 MU J558 --__________________-____ ----------FK-
VS3 MU J558 -____ -------------- ___- ___G------ FK-
VS4 MU J558 L
_____ __N----------- ___- ---- I-----FK_
JV2 MU J558 ----_------_-------_-_---_--- ----------FK-
VS1 MU J606 --K-EE--GG--Q--G-M-L--V---FTLS NFW-- --R--PE-G---VA E-RLKSN-YA-H-AES-K-
JV6 MU J558 0___00-_A_TG------- L -------T__ S-Y-Y ----RP-QG-K--- E--- SH-G-NF-E-FKS41 4
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nonJ558 VHs are preferentially but not exclusively selected when RFs are
generated by secondary protein immunization.
Other V Region Elements
As summarized in Table I, a variety of D genes representing each of the DH
families (44), as well as unidentified D sequences, are used in IgM anti-IgGI
monoclonals. Each of the JHs is used at least once. The combined DJ plus "N"
segments (45) that include all of complementarity determining region (CDR) 3
are subject to length restrictions in certain kinds of antibody responses (18, 26,
46-48). Such a narrow restriction on CDR3 length does not apply to IgM anti-
IgG, as in this set the third CDRs are of a variety of lengths, ranging from 7 to
10 residues. Shorter and longer CDR3s have been observed in other types of
antibodies (49); it is possible that some restrictions on CDR3 length may apply
to heavy chain variable segments found in IgM anti-IgG, autoantibodies. Finally,
only JK1 and JK2 are represented in these sequences; this may reflect either a
preference for these segments or the fact that J.I and JK2 are used in 80% of
splenic B cell V-J rearrangements (50).
IndependentMonoclonal IgM Anti-IgGI Autoantibodies Express Similar
Light Chains in Combination with Dissimilar Heavy Chains
The data presented above show nonrandom selection of light chains and are
consistent with random selection of heavy chains. The finding of instances in
which the same or similar VKs were paired with dissimilar VHs would further
support the notion that there is little restriction on the usage of VH in RFs. Fig.
3 shows two pairwise comparisons of heavy and light chain sequences from two
sets of hybridomas that have similar or identical light chain sequences. In Fig.
3a, the light chains are from two different genes from the VK19 family, and are
82% homologous at the amino acid level and 89% homologous at the nucleotide
level. In contrast, the heavy chains, which are from the 7183 andJ558 families,
are 44% homologous at the amino acid level. A similar picture is presented by
the sequences in Fig. 3b, in which the VK1 light chains are identical except at the
point ofjunctional diversity, whereas the heavy chain amino acid sequences are
42% homologous. In both of these pairs, different DH families, differentJHs, and
different CDR3 lengths are used in the two heavy chains (see Table I). Thus,
not only do heavy chains appear to be randomly represented in the set of IgM
anti-IgG as a whole, but at least for VK19 and VKI genes, very different heavy
chains can associate with similar or identical light chains to generate the RE
specificity.
There Is Very Little Somatic Mutation in IgM Anti-IgGI Autoantibodies
Because RFs express only a small subset of VKs, we have been able to observe
three cases in which the same or nearly the same sequence is expressed in two
independent IgM anti-IgG hybridomas. As outlined below, each of the three
cases almost certainly represents the expression of the same germline gene in the
pairs ofhybridomas. By comparing the nucleotide sequences from each pair with
each other and, when possible, with other published sequences, we have been
able to scan a large tract of sequence for the occurence of somatic mutations.
RF49 and RF51.
￿
The nucleotide sequences of RF49 A and RF51 VK tran-L
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scripts are identical. The amino acid sequences of both of these lines are also
identical to the MPCI I amino acid sequence, including a small duplication in
framework region (FR) 1 which is an idiosyncratic feature of the MPCI I gene
(49, 51). We interpret the sequence identities to mean that RF49 and RF51 are
expressing, in an unmutated form, the same germline gene as MPC11 . Because
the hybridomas have similar specificities, one must consider the otherwise remote
possibility that the identity of the two sequences is the result of both having
undergone identical parallel replacement mutations. However, this is unlikely to
be the case for RF49 and RF51 . Not only do the amino acid sequences match
MPC11, an Ig of unknown specificity, but they also match the nucleotide
sequence from another hybridoma of different specificity (M. Shlomchik, D.
Pisetsky, and M. Weigert, unpublished results.)
VS1 and JV6.
￿
As mentioned above, the VS 1 and JV6 hybrids also express
identical nucleic acid sequences, except at the point of V-J joining. This is
presumptive evidence that the two hybrids express the same germline gene and
that the gene is unmutated in both cell lines. In particular, the amino acid
sequence matches the consensus for the VKIC subgroup (27, 28), and therefore,
both VS 1 andJV6 probably express this germline gene . As with RF49 and RF51,
identical mutations in both hybrids would result in the two having the same
sequence. The possibility of a single parallel mutation can be ruled out by
comparing this sequence with that of hybridomas of different specificity that are
also expressing this gene. Hybridomas from the secondary responsesto oxazolone
(52) express the same VK1C gene. The consensus VK sequence from five inde-
pendent anti-ox hybridomas is also identical to the VS 1 and JV6 V, sequences.
Thus, these chains contain no somatic mutations.
VS4 and JV2.
￿
The VS4 andJV2 lines have VK8 family sequences that differ
by one nucleotide. The most likely interpretation of this is that they are both
expressing the same gene and that one has incurred a somatic mutation. Two
additional VK sequences of IgM anti-IgG2a hybridomas that are identical to JV2
(M . Shlomchik, J. Van Snick, and M. Weigert, unpublished data) support the
idea that the VS4 VK contains a single mutation and theJV2 VK is unmutated.
Based on the above considerations, we have been able to survey ^-2.0 kb of
the VK region for somatic mutation and we have found one mutation . In addition,
the JK and J region sequences in all of the hybrids are identical to the germline
sequences. This represents another ^-600 bases of unmutated sequences. Thus,
the region that we have surveyed contains one mutation in 2.6 kb .
Discussion
We have found that a set of murine IgM anti-IgGI monoclonal autoantibodies
have light chains drawn from a small subset of V, genes and heavy chains drawn
at random from a variety of V genes. This finding is analogous to results of
analysis of human monoclonal RFs. Kunkel and coworkers originally showed
(53, 54) that the majority of human monoclonal RFs have crossreactive idiotypes,
and, by protein sequencing, that most RF light chains belong to the minor VK
IIIb sub-subgroup. The finding of homologous V,t sequences in the Lay and
Pom RF myeloma proteins, however, suggested a role for heavy chains in RF
specificity (55). Subsequently, Chen et al . (56, 57), using antiidiotypic antibodiesSHLOMCHIKET AL.
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against a synthetic peptide corresponding to regions ofa human RF to screen a
panel of monoclonal human RF proteins, showed that the light chains, but not
the heavy chains, were the common element on human RF autoantibodies.
From these correlations of VK, but not V, we infer that anti-IgG specificity is
determined largely or entirely by the light chain. We identified three recurrent
families of VK sequences expressed in hybridomas; a significant percentage of B
cells is expected to express a light chain gene derived from one ofthese families
(see Results). Because our data imply that a variety of Vy, DH, J,,, and JK seem
competent for RF specificity, it follows that many of the B cells expressing RF
VK family genes will also be RF-producing. Therefore, the V gene structure of
RF mAbs provides an explanation for the puzzling observation that a high
fraction ofsplenic B cells express IgM anti-IgG (3, 5).
Assumptions based on the types of VK, JK, V, D, andJ. found in RFs allow us
to derive an estimate of the percentage of B cells containing the proper combi-
nation of V gene segments for the anti-IgG specificity. We have noted that 5-
17% of B cells are expected to express apppropriate VK genes (see Results).J,,s in
our sample are allJ.I orJK2; this could reflect a requirement for these segments
or that 80% of B cells are known to use these two JKs (50). In either case, 80-
100% of B cells are expected to use an appropriate JK. We have observed V
from three gene families which together encompass -80% of all V genes. In
addition, in two cases we found pairs of RFs that had nearly identical light chains
in combination with very different heavy chains. This leads us to conclude that
a variety of heavy chains, perhaps most, could be used for IgGI binding. Our
sample is too small to determine whether other V,, gene families are not
represented because they are inappropriate or because ofstatistical fluctuation.
We are currently expanding our analysis and carrying out other types ofexper-
iments, which will be necessary to delineate exactly what, ifany, restrictions exist
for V gene usage in RFs. Provisionally, we will nonetheless assume that 80% of
B cells express a V competent for anti-IgGI specificity. We have observed
examples ofeach D,, family and all four oftheJs combined to create CDR3s of
a variety of lengths. We take it that most D and JH can be used in RFs (i.e.,
nearly 100% of cells express appropriate D. andJ,,).
Multiplying these percentages gives a value of3-13% ofvirgin B cells expected
to express V gene combinations encoding the anti-IgG specificity. This agrees
remarkably well with the frequency observed in LPS and secondary protein
immunization hybridomas (3-10%). A contrasting result of a similar estimate
from a different antigen-antibody system is one derived by Manser, Huang, and
Gefter (18) for the precursor frequency of the major Ars-CRI. The expression
of this idiotype is thought to depend on single particular genes for each of the
Vregion segments, and can thus be viewed as the opposite extreme ofRE Their
estimate for precursor frequency is quite low: 1 Ars-CRI precursor per 4 X 10'
B cells.
This idea provides a molecular explanation for a high precursor frequency of
IgM anti-IgG1 splenic Bcells. In principle, however, the relatively high frequency
of such B cells could be the result of chronic stimulation by autoantigen and
expansion of a small number of precursors. Several lines of evidence from
previous studies, along with our present data, argue against this alternative: (a)
cell mixing experiments in an in vivo adoptive transfer system have shown that41 8
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unprimed B cells are as effective as primed B cells in producing anti-IgG after
immune complex injection or during a secondary response to a protein antigen;
(6) T cells must be present to generate a response, and unprimed T cells are not
as effective as primed T cells in providing the necessary help (6-8); (c) BALB/c
nu/nu mice make a normal amount of IgM anti-IgG in response to LPS, but they
do not make any IgM anti-IgG in response to immune complexes (indicating that
their high frequency of LPS-driven cells is not the result of endogenous chronic
stimulation, which is absent, as shown by the lack of response to immune
complexes in these mice) (7); (d) all or nearly all anti-IgG activity is of the IgM
isotype, contrary to what would be expected from aresponse basedon chronically
stimulated clones of B cells (3, 5, 58); and (e) the affinity of monovalent IgM
anti-IgG for monovalent IgG is rather low, in contrast to what would be expected
from an "affinity-matured" response to constant stimulation by antigen (52, 59).
A correlative prediction of the chronic stimulation model is that the clonally
expanded IgM anti-IgG should have a high content of somatic mutations (19,
20, 60, 61). In contrast, our data show an exceptionally low content of somatic
mutations in IgM anti-IgG. Thus, we favor the model by which RFs can be
constituted by a restricted set of light chains in combination with a variety of
other variable region segments, thereby accounting for a high precursor fre-
quency of RF-producing cells.
Recognizing that light chains of RFs might be important in determining
specificity, we felt that protein sequence comparisons of IgM anti-IgG a chains
would provide an opportunity to discern regions that were shared among V,
groups found in RFs, but not other V, sequences, and thus that might be
important for conferring the ability to bind IgGI . In Fig. 1, the RF V, sequences
are aligned with representative control sequences (presumably non-RF VKs). The
control sequences represent members of each of the VK families with the same
CDR1 length as VK19, selected because these gene families are more related to
V,19 sequences (which dominate the RF VK sequences) than are other VKs (27).
Although, as expected, the RF light chain sequences within a group are quite
homologous across the entire V region, we failed to find, in any of the three
CDRs, greater self-similarity among the three RF VK families than among control
V, families. To our surprise, we noted instead that the FR2 and FR3 regions of
all of the RF VK sequences are much more related to each other than are control
sequences. This is evident by inspection of Fig. 1. The RF sequences differ from
the consensus RF sequence by zero or one differences in FR2 (average, 0.7), the
control sequences differ by 3-7 residues (average, 4.6); in FR3, the RFs differ
from the consensus by 0-6 residues (average, 3.2), while the control sequences
rz The null hypothesis under test is that particular regions (e.g., FR2) are no more homologous to
each other among the RF V, groups than are non-RF V, groups. Disproving the null hypothesis is
thecriterion for establishing "significant homology." The test was performed by selecting at random
single sequences representative of each V, family found in RFs, and as control to representnon-RF
V,s, single sequences representative of each V, family in length group 35 (as listed by Kabat et al.,
reference 47). All pairwise combinations of sequences within each of the two sets were generated
and the number of differences between each pair was determined. The list of such values derived
from all generated pairs for each set of V, sequences (i.e., RF or control) represents an assessment of
self-similaritywithin that set. The control values presumably are a minimum assessment of expected
self-similarityamongall V,s since the length group 35 V, families are evolutionarily more related to
each other than are randomly selected V, families. The significance of differences between the two
sets of values wasthen assessed by the Mann-Whitney test. Thep values were: CDR1, notdetermined
(because the RF CDRIs are of differentlengths); CDR2, 0.14; and CDR3, 0.21.SHLOMCHIK ET AL.
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differ from the consensus by 10-14 residues (average, 12.0). By the same analysis
used to test CDR homology,' P values determined for FR2 and FR3 were 0.0045
for both. Moreover, a survey of all other VK groups not shown in Fig. 1 reveals
that only one other known VK group (VK22) has a sequence that resembles VK1,
8, and 19 across FR2 and FR3.
The FR2 and FR3 homology in RF V,,s is even more striking when one
considers that the V.1, VK8, and V,19 gene families are divergent in otherregions
of their sequence. As can be seen in Fig. 1, each group has a different CDR1
length and is quite different in sequence from the other two through FR1 and
all CDRs. Adendrogram ofVK relatedness based on protein sequence to the first
invariant tryptophan residue shows V.19 divergingfrom VK8 and V.I at the very
first node; VK1 and VK8 in turn diverge at the second node (27). Similarity of
FR2 and FR3 in RF VK sequences leads us to the unorthodox proposal that these
regions include the combining site for IgGI. A corollary of this hypothesis is
that all of the RF we have sequenced make similar contacts with an Ig constant
domain. Consistent with this is the result that most, but not all, murine RF bind
the CH3 domain of IgG (62).
An important test for a model that postulates antigen contact with FR2 and
FR3 is whether any segments ofthese regions are on the surface ofthe molecule,
therefore accessible for interaction with other molecules. The most appropriate
known three-dimensional structure for approaching this question is that of
MOPC603 (63), which has a VK8 light chain (27) and is very related in FR2 and
FR3 to the RF sequences. As seen in Fig. 4, the protein-chain backbones of FR2
and FR3 trace paths that are almost entirely on the surface of the molecule;
many of the R groups (not shown in Fig. 4) project out and are accessible. In
particular, the central portion ofFR3 is an antiparallel 0 sheet that forms a large
flat surface (Fig. 4a). Contiguous with this surface, but in another plane, is an
accessible region defined by FR2 and some of the N-terminal and C-terminal
residues of FR3 (Fig. 4b). While we have no direct evidence for usage of these
regions in binding, it is clear from their location in the molecule that they could
be used for this purpose. Another indication that FR determinants are accessible
is the finding ofantiidiotypic sera that have been shown to bind FR determinants
(64).
An alternative model for the interaction of IgM anti-IgG with antigen states
that each of the three RF family V,,s uses the traditional antigen-combining site
to bind a different epitope on IgG-CH3. Similarity of CDRs within each of the
RF VK families (see Fig. 1) is the basis for this hypothesis. The strong FR2/3
homology, of the RF VK families is, in this model, ascribed to coincidence. This
is a difficulty, because there are only 4 out of 24 known families that have such
FR2/3 sequences, and the RF families happen to have these sequences in all
three cases. Thus, the probabilityofthis typeofFR sequence randomly occurring
in the three families that bind these hypothetically independent epitopes is no
more than (1/6)3 = (1/216). Another problem for this model is that the light
chain is restricted and the heavy chain is variable in antibodies that bind to each
of the three postulated epitopes. This characteristic is unusual in other antigen-
antibody systems described in the literature. In most cases, only certain combi-
nations of heavy and light chains will allow binding of a given epitope (33, 48,
65-67a) although in a few cases light chain restriction with some degree ofheavy420
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FIGURE 4. Two views of a computer-generated space-filling model of the a carbons of
MCPC603 Fab (reference 63) . Refined coordinates kindly provided by Dr . E . Padlan were
used . Shading of spheres indicates : light, heavy chain ; grey, light chain ; dark grey, light chain
FR2 ; black, light chain FR3 . The figures are oriented so that V region domains are at the top
and C domains at thebottom . (a) Highlights the large, exposed anti-parallel a sheet and bend
of V, FR3 ; (b) highlights the fact that most of theV. FR2 backbone is exposedand that much
of theN-and C-terminal portions of FR3 are similarly exposed, coplanar with theFR2 residues .
The images were produced by first, interactive manipulation of the molecule on the Evans-
Sutherland PS-300 using the DOCK graphics package, developed at the Fox Chase Cancer
Center by W. Wood, F . Manion, and R. Stodola, followed by generation of a space-filling
raster display of selected views using MOLDISP, by R. Stodola, for display on the AED512
raster graphics terminal .
chain variation (19, 65, 67) has been found. It seems unlikely that the same
rather unusual heavy chain promiscuity should apply to all three epitopes .
Because of these two substantial problems, we donot favor this alternative model,
although the present data does not rule it out.
In this connection, we do not believe that the model we favor is contradicted
by recent studies of the human system by Chen et al . (56), which showed that an
anti-CDR2-peptide serum could detect most human RF VKs . This correlation
seems to implicate the CDR2 structure in binding of antigen . However, it is
reasonable to assume that the population of molecules expressing the CDR2
sequences detected by the rabbit antisera would also be expressing homologous
sets ofFR regions . In fact, a concordance ofCDRandFR sequences is evidenced
in the known human RF sequences (see reference 49) . An analogous anti-CDR2-
peptide experiment done in the murine system using a VK19 CDR2 peptide
would give a result similar to that found in the human system, although we know
from the data presented here that nearly all, if not all, murine RF share
homologous FR2 and FR3 sequences .
If, as our results suggest, RF binds an Ig constant domain through an unusual
combining site (FR2/3), then RF can be viewed as antibodies that possess two
functional combining sites, one for IgG-CH3 made up of FR2/3 residues andSHLOMCHIK ET AL.
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theother ofunknown and variable specificity that comprises V-V, CDRresidues.
Since RF are made by a relatively large subset of B cells in which light chains are
derived from three families with dissimilar CDRs and in which heavy chains are
diverse, a large CDR repertoire is probably available in this subset.
Regarding this, it is notable that some monoclonal RF have been found to
have dual specificities (68-71, and D. Nemazee, unpublished observation). Two
interesting examples of polyspecificity are RF that bind a-2-microglobulin (in-
cluding VS1 and VS2, D. Nemazee, unpublished data) and a class of antibody
that has specificity for both an Ig-V region (i.e., they are antiidiotype) and for
the Fc portion of IgG (70, 71) (i .e ., they are RF). We hypothesize that in this
latter class of antibody (termed either "epibodies" or "homobodies," depending
on the network of interactions that induced them), the conventional binding site
interacts with the idiotope because the CDRs of V,1, VK8, or VK19 happen to be
suitable for this purpose, while the FR2 and FR3 of the light chains of these
antibodies mediate IgG binding.
Dual specificity need not always be mediated through two different combining
sites. An alternative and intriguing explanation for crossspecificity for ,0-2-
microglobulin is that a-2-microglobulin and the structure recognized by RF are
both Ig family domains (72) and probably have similar shapes. It is possible then
that recognition of ;Q-2-microglobulin could be via the same combining site that
recognizes IgG-Fc: FR2 and FR3. This is in fact suggested by the complete
divergence of VS 1 and VS2 V and VK sequences in all regions except for VK
FR2 and FR3 (see Figs. 1 and 2).
The VS1 antibody is particularly interesting in this context. It is exceptional
in that it binds a mutant IgGI (IF1) that lacks the CH3 domain ; therefore, VS1
may be recognizing the CH2 domain (D . Nemazee, unpublished data). Since its
light chain type, V.1, is prevalent among RF (this study and M. Shlomchik, J.
Van Snick, D. Pisetsky, and M. Weigert, unpublished data), and since, in one
investigation, 70 of 71 monoclonal RF failed to bind the truncated IgG1 mutant
IF1 (62), it is probable that many V.1-type RF other than VS1 bind CH3, not
CH2. Moreover, we have sequenced an anti-IgG2a RF which in fact binds CH3,
and we found it to be expressing VK1 (M . Shlomchik, J. Van Snick, and M.
Weigert, unpublished data). These considerations raise the possibility that IgG-
CH2 and IgG-CH3 are crossreactive for some RE
In a formal sense, the recognition of IgG by RF represents an interaction
between Ig family domains. It is interesting to speculate that the interaction of
two other Ig family molecules, the T cell receptor and MHC, might be structur-
ally analogous. In particular, the regions of the T cell receptor 0 chain that are
homologous to K FR2 and FR3 might be used to bind one of the MHC domains.
The increased variability reported among 0 chain sequences in these locations
(73) in turn may reflect the need to bind a variety of different MHC alleles
(whereas constancy in these regions for VK reflects evolution to bind a single,
conserved structure: IgG-CH3) . Since all functional T cell receptors must rec-
ognize MHC (74), and since the same V, gene can be used to bind class I and
class II molecules (75, 76), a generic type of binding based on this kind of
interaction between Ig family domains is an attractive possibility for a component
of MHC recognition. Such a model is consistent with a recent report by Yague
et al. (77), in which they characterized a variant of a chicken OVA (cOVA) +422
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I-A"and I-Al-reactive Tcell hybridoma that has lost specific a chain and reactivity
to cOVA + I-AK, but retains alloreactivity to I-Ab.
The nature of the IgM anti-IgG sequences that we have presented here has
led to several hypotheses about the heavy and light chain composition of RF, the
wayin which RF interactswith IgG, and the way Ig family domains may recognize
each other. Although some of these ideas are unconventional, they are testable
and have suggested appropriate chain recombination experiments to explore the
V region structural requirements for IgG binding, as well as biochemical and
structural studies to determine how RF does indeed bind IgG.
Summary
The nucleotide sequences of heavy and light chains from 10 monoclonal IgM
anti-IgGI (RF) antibodies were determined and reported here as translated
amino acid sequences. Only three families of VK light chains were used in these
antibodies: V.I (two examples), VK8 (three examples), and V.19 (four examples).
This represents a significant nonrandom selection of light chains. In contrast, all
other variable region gene segments (i .e ., V, D, J., and J.) were used in a
pattern consistent with random selection from the available pool of germline
genes. In two cases, the same anti-IgGI specificity was generated by a combina-
tion of very homologous light chains with unrelated heavy chains. We infer from
this that the light chain is the segment used by these antibodies to bind IgG1.
The nature of these sequences provides an explanation for the curious obser-
vation that as many as 15% of splenic B cells in normal mice may be expressing
IgM anti-IgG; if, as our data suggest, certain light chains in combination with
many different heavy chains can be used in assembling the anti-IgG specificity,
then, because ofcombinatorial association in which the heavychain is notrelevant
for specificity, the fraction of IgM-producing B cells expressing these light chains
should approximate the fraction of B cells making IgM anti-IgG. We calculate,
based on data presented in several other studies, that 5-17% of B cells express
one of the VK types observed in monoclonal RE This agrees well with estimates
for the number of B cells making IgM anti-IgG. In addition, our findings could
rule out other explanations of the high percentage of B cells making RF, such as
constant stimulation by antigen or presence of numerous antigenic epitopes since
it was shown that IgM anti-IgG 1 antibodies are not somatically mutated and that
they are structurally homogeneous.
We aligned the VK sequences of the RF in hopes of finding some primary
sequence homology between the represented VK families which might point to
residues involved in the binding interaction. Although we found no such homol-
ogy in the hypervariable regions, we did find significant and unexpected homol-
ogy in the FR2 and FR3 of these light chains. We noted that these regions are
exposed in the Ig structure and postulate that they may be involved in a unique
type of binding interaction between two Ig family domains, i.e., VK binding to a
constant region domain of IgG.
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